Genetics Generation Advancement (ROCO:4160) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4160 Genetics Generation Advancement Corp ROCO:4160
70 GF Score
Price NT$41.15
GF Value NT$51.35
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Genetics Generation Advancement Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Genetics Generation Advancement's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ROCO:4160 vs TMO, DHR, IDXX: Margin of Safety % (DCF Earnings Based) Comparison

For the Diagnostics & Research subindustry, Genetics Generation Advancement's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetics Generation Advancement Margin of Safety % (DCF Earnings Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetics Generation Advancement's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Genetics Generation Advancement's Margin of Safety % (DCF Earnings Based) falls into.


ROCO:4160
70GF Score
Genetics Generation Advancement Corp ROCO:4160
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genetics Generation Advancement (ROCO:4160) Overvalued in 2026?

Based on GuruFocus' analysis, Genetics Generation Advancement stock appears to be undervalued. The current stock price of NT$41.15 is trading 19.9% below its estimated GF Value™ of NT$51.35. GuruFocus considers Genetics Generation Advancement to be Modestly Undervalued.

Key valuation signals for ROCO:4160:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: NT$51.35 vs. price of NT$41.15 (19.9% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genetics Generation Advancement Business Description

Address No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.
70GF Score

Get the complete analysis for ROCO:4160

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.15
Price
NT$51.35
GF Value